Cellebrite DI (CLBT) Shares Outstanding (Weighted Average) (2019 - 2025)
Cellebrite DI's Shares Outstanding (Weighted Average) history spans 7 years, with the latest figure at $241.6 million for Q4 2025.
- Quarterly Shares Outstanding (Weighted Average) rose 15.35% to $241.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $241.6 million through Dec 2025, up 15.35% year-over-year, with the annual reading at $241.6 million for FY2025, 17898145.63% up from the prior year.
- Shares Outstanding (Weighted Average) came in at $241.6 million for Q4 2025, up from $240.0 in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $241.6 million in Q4 2025 to a low of $30.0 in Q2 2021.
- The 5-year median for Shares Outstanding (Weighted Average) is $420.0 (2022), against an average of $48.4 million.
- Year-over-year, Shares Outstanding (Weighted Average) plummeted 95.0% in 2023 and then soared 4900.0% in 2024.
- Cellebrite DI's Shares Outstanding (Weighted Average) stood at $144.0 million in 2021, then increased by 26.87% to $182.7 million in 2022, then grew by 4.08% to $190.2 million in 2023, then increased by 10.16% to $209.5 million in 2024, then increased by 15.35% to $241.6 million in 2025.
- Per Business Quant, the three most recent readings for CLBT's Shares Outstanding (Weighted Average) are $241.6 million (Q4 2025), $240.0 (Q3 2025), and $150.0 (Q2 2025).